Drug-eluting stents for the treatment of intracranial atherosclerosis: Initial experience and midterm angiographic follow-up

Stroke

Volumn 36, Issue 12, 2005, Pages

  Abou Chebl, Alex ^a   Bashir, Qasim ^a   Yadav, Jay S ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Angiography; Intracranial arterial diseases; Ischemia; Stents

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; PACLITAXEL; RAPAMYCIN;

ADULT; AGED; ARTICLE; BASILAR ARTERY; BRAIN ANGIOGRAPHY; BRAIN ATHEROSCLEROSIS; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; INTERNAL CAROTID ARTERY; MALE; MIDDLE CEREBRAL ARTERY; PRIORITY JOURNAL; RESTENOSIS; VERTEBRAL ARTERY; CLINICAL TRIAL; DRUG IMPLANT; ECHOGRAPHY; MIDDLE AGED; PROSPECTIVE STUDY; RADIOGRAPHY; STENT;

ADULT; AGED; CEREBRAL ANGIOGRAPHY; DRUG IMPLANTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; MALE; MIDDLE AGED; PACLITAXEL; PROSPECTIVE STUDIES; SIROLIMUS; STENTS;

EID: 33644691065     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000190893.74268.fd     Document Type: Article

References (9)

1. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke. 2004; 35:1388-1392.
2. Holmes DR Jr, Leon MB, Moses JW, Popma JJ, Cutlip D, Fitzgerald PJ, Brown C, Fischell T, Wong SC, Midei M, Snead D, Kuntz RE. Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis. Circulation. 2004; 109:634-640.
3. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME; TAXUS-IV Investigators. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial. Circulation. 2004; 109:1942-1947.
4. Levy EI, Hanel RA, Howington JU, Nemes B, Boulos AS, Tio FO, Paciorek AM, Amlani S, Kagan-Hallett KS, Fronckowiak MD, Guterman LR, Hopkins LN. Sirolimus-eluting stents in the canine cerebral vasculature: a prospective, randomized, blinded assessment of safety and vessel response. J Neurosurg. 2004; 100:688-694.
5. Mori T, Fukuoka M, Kazita K, Mori K. Follow-up study after percutaneous transluminal cerebral angioplasty. Eur Radiol 1998; 8:403-408.
6. Jiang WJ, Wang YJ, Du B, Wang SX, Wang GH, Jin M, Dai JP. Stenting of symptomatic M1 stenosis of middle cerebral artery: an initial experience of 40 patients. Stroke. 2004; 35:1375-1380.
7. Moreno R, Fernandez C, Hernandez R, Alfonso F, Angiolillo DJ, Sabate M, Escaned J, Banuelos C, Fernandez-Ortiz A, Macaya C. Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol. 2005; 45:954-959.
8. Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, Leys D, Matias-Guiu J, Rupprecht HJ; MATCH investigators. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet. 2004; 364:331-337.
9. Rothwell PM. Lessons from MATCH for future randomised trials in secondary prevention of stroke. Lancet. 2004; 364:305-307.